>
American billionaire reveals ambitious plans for high-tech floating city off the US coast
Thousands of flights delayed across the country after Delta outage triggers chaos ahead...
"They're Hiding Pedophiles": Only 23 Of 321 California School Districts Handed Over Te
Iran Dangles Deal As Bahrain Burns, Houthi Missiles Fly At Riyadh
Dubai Just Finished the World's First Permanent Air Taxi Route: Airport to the Marina in Under 1
Doroni Aerospace Raises More than $60m for H1?X Development
After 13 Years Battling Cancer, a 61-Year-Old Brazilian Man Achieved Complete Remission...
Extraterrestrial habitats may rise via Legos of laser-fused moon dust
Battery-only 19-seater puts China in the electric airliner race
Dream Chaser space plane gets landing approval for debut mission in 2027
SpaceX Just Caught Starship on Its FIRST Attempt!
Solid-State Cells Can Make The U.S. Competitive In Batteries Again: CEO
Jetson ONE personal eVTOL pod is about to go full sky patrol
America's INSANE BREAKTHROUGH Could Replace Septic Tanks Forever

An exciting new study says that exposure to blue light is an effective, non-pharmaceutical treatment for high blood pressure, which simultaneously reduces the risk of developing cardiovascular disease.
During this study, which was published in the European Journal of Preventative Cardiology, participants were exposed to 30 minutes of whole-body blue light at approximately 450 nanometers – a dose comparable to daily sunlight – followed by exposure to a control light on a different day.
Visible blue light, as opposed to ultraviolet (UV) light, is not carcinogenic. To assess the impact, participants' blood pressure, stiffness of arteries, blood vessel dilation, and blood plasma levels of nitric oxide stores were measured—before, during, and up to two hours after irradiation with both lights.
The researchers who conducted the study from the University of Surrey and Heinrich Heine University Duesseldorf discovered that exposure to whole-body blue light significantly reduced the systolic blood pressure of participants by almost 8 mmHg, compared to the control light which had no impact.